Stay updated on Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page
- Check7 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check42 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.2 was added and the funding/operating-status notice was removed. The core study content and page structure remain unchanged.SummaryDifference0.4%

- Check78 days agoChange DetectedAdded a government funding notice indicating the site may not be up to date and that the NIH Clinical Center is open, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedAdded a 'Show glossary' option and updated the page with new footer/metadata elements. The page now lists 'Last Update Submitted that Met QC Criteria', includes a 'No FEAR Act Data' link, and shows version 'v3.4.0' (replacing 'v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.